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Abstract
Modulation of host DNA synthesis is essential for many viruses to establish productive infections and contributes to viral
diseases. Human cytomegalovirus (HCMV), a large DNA virus, blocks host DNA synthesis and deregulates cell cycle
progression. We report that pUL117, a viral protein that we recently identified, is required for HCMV to block host DNA
synthesis. Mutant viruses in which pUL117 was disrupted, either by frame-shift mutation or by a protein destabilization-
based approach, failed to block host DNA synthesis at times after 24 hours post infection in human foreskin fibroblasts.
Furthermore, pUL117-deficient virus stimulated quiescent fibroblasts to enter S-phase, demonstrating the intrinsic ability of
HCMV to promote host DNA synthesis, which was suppressed by pUL117. We examined key proteins known to be involved
in inhibition of host DNA synthesis in HCMV infection, and found that many were unlikely involved in the inhibitory activity
of pUL117, including geminin, cyclin A, and viral protein IE2, based on their expression patterns. However, the ability of
HCMV to delay the accumulation of the mini-chromosome maintenance (MCM) complex proteins, represented by MCM2
and MCM4, and prevent their loading onto chromatin, was compromised in the absence of pUL117. When expressed alone,
pUL117 slowed cell proliferation, delayed DNA synthesis, and inhibited MCM accumulation. Knockdown of MCM proteins by
siRNA restored the ability of pUL117-deficient virus to block cellular DNA synthesis. Thus, targeting MCM complex is one
mechanism pUL117 employs to help block cellular DNA synthesis during HCMV infection. Our finding substantiates an
emerging picture that deregulation of MCM is a conserved strategy for many viruses to prevent host DNA synthesis and
helps to elucidate the complex strategy used by a large DNA virus to modulate cellular processes to promote infection and
pathogenesis.
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Introduction
The manipulation of host DNA synthesis is a critical step for
many DNA viruses, including human cytomegalovirus (HCMV),
to establish productive infection leading to disease [1,2,3]. HCMV
is a prototypical b-herpesvirus, a ubiquitous pathogen, and one of
the most common causes of birth defects in newborns and life-
threatening disease in immunocompromised individuals. Despite
its slow replication kinetics, HCMV can efficiently infect, persist,
and establish latency in humans. To accomplish this, HCMV
encodes at least 166 annotated genes, many of which act to hijack
and deregulate key cellular processes, such as cellular DNA
synthesis and cell cycle control [4].
HCMV infection induces a cellular environment conducive for
DNA replication but in the meantime specifically blocks host DNA
synthesis, thereby arresting host cells in a pseudo-G1 phase [5,6].
It is proposed that such modulation allows the virus to divert
resources, such as energy, nucleotide pools, and cellular DNA
replication enzymes, exclusively for viral DNA replication.
Consistent with this notion, cells that actively replicate their
DNA fail to support a lytic HCMV infection. Instead, they
progress through S phase and arrest at the next G1-phase after
mitosis to initiate HCMV replication [7,8].
HCMV encodes multiple factors, both stimulatory and
inhibitory, to tightly regulate host and viral DNA replication for
a successful infection (reviewed in [5,6,9]). Over-expression of
HCMV protein pp71, IE1, IE2, or pUL97 inactivates pRb-family
proteins, activates expression of E2F-dependent S-phase genes,
and promotes G1/S- transition. On the other hand, pUL69
[10,11] and IE2 [12] are required for HCMV to block cellular
DNA synthesis. Over-expression of IE2 inhibits cyclin A
transcription, induces p16 expression, and arrests cells in S phase
[13,14,15,16]. The mechanism for the cell-cycle arresting activity
of pUL69 remains unknown. These viral factors must act in
PLoS Pathogens | www.plospathogens.org 1 March 2010 | Volume 6 | Issue 3 | e1000814conjunction at multiple regulatory levels in order for HCMV to
manipulate the host cell cycle. Neither IE2 nor pUL69 alone
blocks cellular DNA synthesis during infection, because a mutant
HCMV expressing one but not the other fails to arrest host cells at
a pseudo-G1 phase [10,12]. In addition to cellular proteins
involved in cell cycle control, HCMV directly targets DNA
replication factors, such as mini-chromosome maintenance
(MCM) complex [17,18]. MCM, a hetero-hexameric protein
complex composed of MCM2-MCM7, is recruited by Cdc6 and
Cdt1 to replication origins, forming pre-replication complexes
(pre-RC) during late M- to G1- phase to allow replication
licensing. Once activated by cyclin-dependent kinase 2 and Dbf4-
dependent kinase (Dbf4/cdc7) in S phase, MCM acts as a
replicative helicase to unwind the origin and initiate DNA
replication [19]. HCMV inhibits loading of MCM onto chromatin
to prevent cellular replication licensing [17,18], and this inhibitory
activity appears to correlate with virus-induced early accumulation
of geminin, a negative regulator of the assembly of pre-replication
complexes [18].
We previously identified a protein product of HCMV early gene
UL117, termed pUL117 [20]. We showed that pUL117-deficient
HCMV replicated viral DNA at slightly reduced levels but was
markedly delayed in the maturation of viral replication compart-
ments and severely attenuated in growth in human foreskin
fibroblasts [20]. In this study, we investigated the potential role of
pUL117 in manipulating host cells during HCMV infection. We
report that pUL117 is necessary and sufficient to reduce the
accumulation of MCM proteins. During HCMV infection
pUL117 may also have a direct role in preventing MCM loading
onto chromatin. Importantly, knockdown of MCM proteins
restored the ability of pUL117-deficient virus to block cellular
DNA synthesis. Thus, targeting MCM function is a mechanism for
pUL117 to help block cellular DNA synthesis during HCMV
infection. These findings reveal a novel strategy used by HCMV to
usurp the host DNA replication machinery, and provide new
insight into the complex host-pathogen interactions fundamental
to the biology and pathogenesis of the virus.
Results
pUL117 is required for HCMV to block cellular DNA
synthesis during infection
We previously discovered that pUL117 was required for the
proper maturation of nuclear viral replication compartments and
efficient HCMV infection in primary human foreskin fibroblasts
(HFFs) [20]. Here, we asked if pUL117 functioned by targeting
host factors involved in cellular DNA replication and cell cycle
control. HCMV infection blocks cellular DNA synthesis and
predominantly arrests permissive cells in a phenotypically G1-like
phase [5,6]. To test whether this activity required pUL117,
actively growing HFFs were mock-infected, infected with wild type
virus (ADwt) or pUL117-deficient virus (ADdlpUL117). Nocoda-
zole was added 8 hours post infection (hpi) to prevent cell division,
and the DNA content was analyzed by flow cytometry-based cell
cycle analysis at 48 hpi (Fig. 1A). 45% of mock-infected cells
reached G2/M by this time point. As anticipated, wild type
HCMV infection efficiently blocked host DNA synthesis with only
24% of cells reaching G2/M at 48 hpi, and this population of cells
likely represented uninfected bystanders or abortively-infected
cells. However, pUL117-deficient virus failed to block host DNA
synthesis, allowing 52% of cells to progress to G2/M. In wild type
virus infected cells, broadening of the G1 peak was observed as a
result of viral DNA synthesis [21]. Broadening of the G1 peak was
less evident in ADdlpUL117 infected cells at this time point, likely
due to the slight delay of viral DNA synthesis [20]. To eliminate
potential complications due to viral DNA synthesis, we also
analyzed the DNA content of cells after infection in the presence of
ganciclovir (GCV), a specific inhibitor of HCMV DNA synthesis
(Fig. 1B). The results showed that GCV, at concentrations of 13
and 30 mg/ml, blocked the broadening of the G1 peak, indicative
of viral DNA synthesis inhibition. Thus, while wild type HCMV
maintained its ability to block host DNA synthesis, mutant virus
failed to do so and cells entered S phase and progressed to G2/M
phase.
As all HCMV viruses used in this study were tagged with GFP,
we specifically analyzed the DNA content of GFP-positive infected
cells by sorting cells based on GFP expression. Sorting was efficient
as 99% of sorted cells were GFP positive (data not shown). Upon
ADwt infection, only 6% of infected cells reached the S- or G2/M-
phase, whereas upon ADdlpUL117 infection, 16% and 38% of
cells reached S and G2/M, respectively (Fig. 2A). Thus, unlike
ADwt infection, the mutant virus did not block host DNA
synthesis. It is known that abortive HCMV infection is unable to
block host DNA synthesis [22,23,24]. However, this was not the
case here because pUL117-deficient virus established productive
infection, producing infectious progeny even though the kinetics of
its viral DNA replication was slightly delayed in HFFs [20]. This
was further supported by the observation that 93–94% of wild type
and mutant virus infected cells that were GFP-positive also
expressed early viral protein pUL44, confirming that both viruses
were able to establish productive infection equally well (Fig. 2B
and Figure S4). In this study, we used HCMV-driven GFP or viral
proteins pUL44 (DNA polymerase processivity factor) or IE1/IE2
(immediate early proteins) interchangeably as markers of produc-
tive infection as they all identified the same cell populations during
infection (data not shown).
Author Summary
Inhibition of host DNA synthesis is pivotal for many viruses
to establish productive infection and cause disease.
Human cytomegalovirus (HCMV) is the top viral cause of
birth defects in newborns and leads to life-threatening
diseases in individuals with compromised immunity. HCMV
blocks host DNA synthesis and creates a cellular environ-
ment to replicate its own genome. We report here that
pUL117, a novel viral protein that we recently identified, is
required for HCMV to block host DNA synthesis. Mecha-
nistically, pUL117 is necessary and sufficient to reduce the
accumulation of the mini-chromosome maintenance
(MCM) complex, a replicative helicase that unwinds the
origin and initiates cellular DNA replication. During HCMV
infection pUL117 may also have a direct role in preventing
MCM loading onto chromatin. Importantly, knockdown of
MCM proteins restored the ability of pUL117-deficient
virus to block cellular DNA synthesis. Thus, targeting MCM
function is a mechanism for pUL117 to help block cellular
DNA synthesis during HCMV infection. Several proteins
encoded by other viruses have also been reported to
subvert MCM function by distinct mechanisms and inhibit
host DNA synthesis when over-expressed in host cells.
Therefore, MCM has emerged as a conserved target for
viruses to prevent host DNA synthesis. Our results illustrate
a novel strategy that HCMV uses to manipulate this critical
cellular factor during infection. This study helps to
elucidate the sophisticated strategies used by a large
DNA virus to modulate cellular processes to promote
infection and pathogenesis and may also shed light on the
regulation of eukaryotic DNA replication.
HCMV Protein pUL117 Suppresses Host DNA Synthesis
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closely during infection, we gated infected cells by IE1/IE2 and
analyzed their DNA content at both 24 and 48 hpi (Fig. 2C).
Infection was carried out in the presence of GCV to prevent viral
DNA replication. At 24 hpi, although slightly more mutant virus-
infected cells (6% and 16%) than wild type virus-infected cells (2%
and 15%) progressed to S-phase and G2/M phase, the mutant
infection still blocked host DNA synthesis quite efficiently when
compared to mock infection (3% and 28%) (Fig. 2C). However, as
expected, while ADwt infection maintained this inhibitory activity
at 48 hpi, the mutant virus was unable to block host DNA
synthesis of actively growing HFFs at this time point.
To better define how pUL117 modulates host DNA synthesis,
we examined its impact on the DNA profile of HFFs that were
synchronized at G0 prior to HCMV infection, a condition that has
been widely used to investigate the modulation of cell cycle and
cellular DNA synthesis by HCMV. We synchronized subconfluent
HFFs at G0 by serum starvation, infected them with mock or
recombinant HCMV in the presence of serum, GCV, and
nocodazole, and analyzed the DNA content of infected cells that
were gated for expression of viral protein pUL44 (Fig. 3). More
than 99% of cells infected with either wild type or mutant virus
were pUL44 positive, indicating a robust productive infection
(Fig. 3A). The overall cell cycle progression of serum-stimulated
quiescent mock-infected cells or cells infected with mutant virus
was delayed compared to actively growing cells. Nonetheless, as
anticipated, while a total of 35% of mock-infected cells moved into
S-phase (7%) and G2/M-phase (28%) at 48 hpi, wild type HCMV
blocked host DNA synthesis, resulting in only 18% of pUL44+
cells moving into S-phase (9%) and G2/M-phase (9%). In contrast,
pUL117-deficient virus failed to block host DNA synthesis, and
34% of pUL44+ cells moved into S-phase (19%) and G2/M-phase
(15%) (Fig. 3B). This defect was further confirmed by direct
measurement of DNA synthesis with
3H thymidine incorporation
at 48 hpi (Fig. 3C). The amount of GCV-resistant, replicating
DNA in cells infected with mutant virus (232%) was ,30-fold
higher than that in cells infected with wild type virus (8%).
The resistance of DNA replication in pUL117 deficient virus-
infected cells to GCV indicated that we were selectively
monitoring cellular DNA synthesis. In support of this, GCV was
found to inhibit viral DNA synthesis equally well in cells infected
with wild type or mutant virus (Fig. 3D). GCV treatment resulted
in ,80-fold reduction of viral DNA accumulation in both wild
type and mutant virus infected cells at 48 hpi. Importantly, in the
presence of GCV, the residual viral DNA in mutant virus infected
cells was 2.6-fold less than that in wild type virus infected cells.
Furthermore, the elevated DNA content seen in cells infected with
mutant virus as compared to wild type virus was recapitulated
when viral DNA replication was inhibited by another specific viral
DNA synthesis inhibitor, phosphonoacetic acid (PAA) (Figure S1).
It was noted that, similar to infection in actively growing HFFs
(Fig. 2C), in G0-synchronized HFFs the inability of pUL117-
deficient virus to block host DNA synthesis at 24 hpi was less
pronounced than that at 48 hpi (Fig. 3B and Figure S1). It is also
important to note that progress through S-phase was delayed
during infection of mutant virus as compared to mock-infected
cells at 48 hpi, both in actively growing HFFs (Fig. 2C, 23% of
infected cells versus 12% of mock) and in G0-synchronized HFFs
(Fig. 3B, 19% of infected cells versus 7% of mock). These results
suggest that other viral factors, such as IE2 and pUL69, are able to
block host DNA synthesis at early times and they may also institute
additional blockades in S phase in the absence of pUL117 at times
after 24 hpi.
Collectively, these results are consistent with the notion that
HCMV encodes multiple factors to modulate the DNA replication
machinery of host cells, and importantly, our results demonstrate
that pUL117 is required for HCMV to block host DNA synthesis
at times after 24 hpi.
HCMV has an ability to stimulate cellular DNA synthesis
in the absence of pUL117
A major strategy employed by many DNA viruses to replicate
their genomes is to promote host cell entry into S-phase in order to
utilize the cellular resources needed for viral DNA synthesis. The
HCMV UL97 protein has cyclin-dependent kinase (CDK) activity,
allowing the virus to inactivate Rb-family proteins and activate
transcription of S-phase genes [1,25]. Earlier studies have also
shown that HCMV induces the expression of cellular genes
needed for DNA replication, such as the ones encoding the pre-
RC components [17,18]. Thus, HCMV may have an ‘‘intrinsic’’
ability to stimulate cellular DNA synthesis, and that this
Figure 1. UL117-deficient virus failed to block host DNA
synthesis during infection of actively growing human foreskin
fibroblasts (HFFs). Actively growing HFFs were mock-infected, or
infected with wild type HCMV (wt), or pUL117-deficient virus
(dlpUL117), and nocodozale was added 8 hours post infection (hpi).
At 48 hpi, cells were stained with propidium iodide (PI) and their DNA
content was determined by flow cytometry based cell cycle analysis. (A)
HFFs that were mock-infected or infected with recombinant HCMV
without gancyclovir (GCV) treatment. (B) HFFs that were infected in the
presence of GCV at indicated concentrations.
doi:10.1371/journal.ppat.1000814.g001
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was supported by the observation that when infecting cycling cells,
ADdlpUL117 infection promoted a greater number of cells to
move out of G1 compared to mock-infected cells at 48 hpi
(Fig. 2C) and 72 hpi (data not shown). To test the hypothesis
directly, we synchronized HFFs in G0 by contact inhibition and
serum starvation, infected them with HCMV in the presence of
GCV and nocodazole but without serum (to prevent serum-
stimulated re-entry of cells into the cell cycle), and then analyzed
infected cells for their DNA content by flow cytometry and for
DNA synthesis by
3H thymidine incorporation (Fig. 4). At 96 hpi,
while very few mock infected (2%) or wild type virus-infected cells
(6%) entered S phase, pUL117-deficient virus stimulated entry of
host cells into S phase (21%) (Fig. 4A). Direct measurement of
thymidine incorporation confirmed elevated levels of DNA
replication in mutant virus-infected cells under conditions of
serum starvation and contact inhibition (Fig. 4B). This result
suggests that HCMV has the intrinsic ability to drive host cells to
initiate cellular DNA synthesis, but this stimulatory activity is
blocked by pUL117.
Inability of pUL117-deficient virus to block host DNA
synthesis is due to the absence of pUL117 expression
It was conceivable that viral stocks of ADdlpUL117 used for
infection in our study might differ from those of wild type virus in
composition or virion structures, and this physical difference of the
seed stocks rather than the lack of pUL117 expression during
Figure 2. pUL117 was required to block host DNA synthesis of HCMV-infected cells at late times during infection. Actively growing
HFFs were mock-infected, or infected with wild type HCMV (ADwt), or pUL117-deficient virus (ADdlpUL117), and nocodozale was added 8 hpi. (A)
Cells were sorted by HCMV-driven GFP expression at 48 hpi, stained with PI, and GFP+ cells were analyzed for their DNA content by flow cytometry.
(B) Cells were fixed and labeled with the antibody to viral protein pUL44 (a-pUL44) at 48 hpi. Cellular distributions of GFP and pUL44 signals were
analyzed by two-color flow cytometry. Specificity of GFP or pUL44 signal was demonstrated by analyzing infection of recombinant HCMV ADwt-cre
that did not express GFP [53] or ADwt without pUL44 staining, respectively. (C) Cells were infected in the presence of GCV (30mg/ml), double-stained
with PI and the antibody to viral proteins IE1/IE2 at 24 and 48 hpi, and IE1/IE2+ cells were determined for their DNA content.
doi:10.1371/journal.ppat.1000814.g002
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synthesis when cells were infected. This was unlikely since there
was no evidence for the presence of pUL117 in HCMV virions
[26] and the mutant virus was capable of blocking cellular DNA
synthesis at early times during infection (Figs. 2C and 3A).
Nonetheless, to provide direct evidence we made a recombinant
HCMV in which the UL117 ORF was tagged with a FKBP
destabilization domain (ddFKBP) at its amino terminus
(ADpFKBP-UL117). The fusion protein pFKBP-UL117 was
directed for rapid degradation by ddFKBP, but could be stabilized
Figure 3. pUL117 was required to block host DNA synthesis of G0-synchronized HFFs during HCMV infection. Subconfluent HFFs were
synchronized at G0 by serum starvation and then infected with recombinant HCMV in the presence of serum. Nocodazole was added at 8 hpi. (A and
B) Cells were infected in the presence of GCV (30mg/ml), double-stained with PI and a-pUL44 at 24 and 48 hpi, and analyzed by flow cytometry for
their DNA content and pUL44 expression. Shown is a representative of three reproducible, independent experiments. (A) Signal profiles of pUL44 (x-
axis) and PI (y-axis) of mock- or virus- infected cells at 48 hpi. Cells within gate R3 or R4 represents pUL44-negative or pUL44-positive cells,
respectively. (B) Mock-infected cells in R3 and virus-infected cells in R4 were analyzed for their DNA content. Percentages of cells in S-phase or G2/M-
phases were shown as solid or open bars, respectively. (C) The rate of DNA synthesis of infected cells with or without GCV (30mg/ml) was measured by
[
3H] thymidine incorporation at 48 hpi. Shown are relative amounts of incorporated [
3H] thymidine in each sample with thymidine incorporation in
mock-infected cells in the absence of GCV set at 100%. (D) Accumulation of viral DNA in infected cells with or without GCV (30mg/ml) was measured
by realtime-quantitative PCR at 48 hpi.
doi:10.1371/journal.ppat.1000814.g003
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approach has recently been used to generate conditional HCMV
mutants in which ddFKBP was fused to three essential viral genes
to regulate accumulation of these fusion proteins and viral growth
[29]. This approach provided a rapid and reversible way to
regulate the accumulation of pUL117 in infections from the same
viral stock. We predicted that infection would be pUL117-
deficient without Shld1 (pFKBP-UL117 unstable) but would be
wild type with Shld1 (pFKBP-UL117 stable).
HCMV virus prepared without Shld1 was used to infect actively
growing HFFs incubated with or without Shld1, and viral protein
accumulation and cell cycle distribution of infected cells were
analyzed at 48 hpi. Shld1 only had negligible effect on
accumulation of viral proteins pUL117, pUL117.5, and IE1
(Fig. 5A), modulation of the cell cycle progression (Fig. 5B), or
replication of ADwt or ADdlpUL117 (data not shown). With
Shld1, the pFKBP-UL117 fusion protein was stabilized and
ADpFKBP-UL117 effectively blocked host DNA synthesis. In
contrast, without Shld1, the accumulation of the FKBP-UL117
fusion protein was greatly reduced (Fig. 5A) and recombinant virus
failed to prevent host DNA synthesis (Fig. 5B). Thus, altered
modulation of host DNA synthesis in pUL117-deficient virus was
the direct result of abrogation of pUL117 expression rather than
physical differences between wild type and mutant viral stocks.
pUL117 blocks accumulation of MCM proteins and their
loading onto chromatin during HCMV infection
To dissect the mechanism of pUL117 function, we examined
several key cellular factors that regulate cellular DNA replication
and are perturbed by HCMV infection. We were particularly
interested in events occurring at times prior to the failure of the
pUL117-deficient virus to block host DNA synthesis (i.e., 0–
36 hpi) as misregulation of these events was the most likely cause
of the defect. HCMV up-regulates p16 at late times [13,30],
inhibits cyclin A accumulation [8,31,32], and prevents MCM
complex loading onto chromatin [17,18]. When infecting G0-
synchronized HFFs in the presence of serum, HCMV induced p16
accumulation and expressed another viral inhibitory protein IE2
independent of pUL117 (Fig. 6A and Figure S2). HCMV also
regulated the accumulation of two other cellular regulatory
Figure 4. pUL117-deficient virus stimulated host DNA synthesis of quiescent HFFs in the absence of serum. HFFs were synchronized at
G0 by serum starvation and contact inhibition, and then infected with recombinant HCMV with GCV (30mg/ml) but without serum. (A) Nocodazole
was added at 8 hpi and the percentage of IE1/IE2+ cells in S-phase was determined by flow cytometry at indicated times post infection. Shown is a
representative of three reproducible, independent experiments. (B) The rate of DNA synthesis of infected HFFs at 72 or 96 hpi was measured by [
3H]
thymidine incorporation. *, P,0.05; **, P,0.01 by Student’s t test.
doi:10.1371/journal.ppat.1000814.g004
Figure 5. Lack of newly synthesized pUL117 was directly responsible for the failure of pUL117-deficient virus to block host DNA
synthesis. Recombinant HCMV virus ADpFKBP-UL117 carried a functional pUL117 variant that was tagged with a FKBP destabilization domain at its
N terminus (pFKBP-UL117). HFFs were infected with ADpFKBP-UL117 with or without stabilizing ligand Shld1 (1mM). Nocodozale was added at 8 hpi,
infected cells were harvested at 48 hpi, the accumulation of pUL117 or pFKBP-UL117 was determined by immunoblotting analysis (A), and the DNA
content by flow cytometry (B). Percentages of cells in S-phase or G2/M-phases were shown as solid or open bars, respectively.
doi:10.1371/journal.ppat.1000814.g005
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S2). Both wild type and pUL117-deficient viruses inhibited
accumulation of cyclin A during infection (Fig. 6A). This was
anticipated because the mutant virus expressed IE2, which has
been known to inhibit cyclin A accumulation [14], and was
consistent with S-phase delay observed in mutant virus infection
(Figs. 2C and 3A). Interestingly, mutant virus appeared to inhibit
cyclin A to an even greater extent than wild type virus (Fig. 6A).
This inhibition could not explain elevated cellular DNA seen in
mutant virus infection because in normal cells cellular DNA
synthesis and S-phase progression correlates with cyclin A
accumulation. This result also suggested that the cell cycle
proceeded, albeit with delayed kinetics, in fibroblasts even when
cyclin A level was reduced. Indeed, it has been shown that
depletion of cyclin A does not prevent proliferation of fibroblasts
[33] or cellular DNA synthesis [34]. Thus, we found no evidence
for a role of viral protein IE2, cellular cell cycle regulatory proteins
p16, p21, p53, or cyclin A in elevated cellular DNA synthesis in
pUL117-deficient virus infection.
In striking contrast, the ability of HCMV to modulate the
MCM complex, a key component of replication licensing, was
altered in the absence of pUL117 (Fig. 6A). In mock-infected cells,
Figure 6. pUL117-deficient virus failed to block accumulation and chromatin loading of MCM components. Subconfluent HFFs were
synchronized at G0 by serum starvation, and then infected with recombinant HCMV in the presence of serum. (A) At indicated times, total lysate or
chromatin fractions from equal number of cells were analyzed by immunoblotting for viral and cellular factors known to modulate the cell cycle and
DNA replication. Also shown were pUL117-related proteins and actin control. (B) Amounts of MCM2 and MCM4 in total cell lysates or chromatin
fractions from equal number of infected cells at 24 and 30 hpi were quantified as described in Materials and Methods. The ratio of MCM in mutant
virus infection to that in wild type virus infection was calculated. Shown are the averages of the results from three independent sets of infections.
*, P,0.05; **, P,0.01 by Student’s t test. (C) The completion of fractionation was determined by immunoblotting of viral protein IE1 and cellular
protein Lamin A in soluble and chromatin fractions. (D) At indicated times post infection, RNA from infected cells was extracted, treated with TURBO
DNA-free reagent (Ambion) to remove contaminating DNA, and the amounts of MCM4 and GAPDH control transcripts were determined by reverse
transcription-couple realtime-quantitative PCR analysis. All data sets were within the linear ranges of standard curves shown in Figure S5. The amount
of MCM4 transcript was then normalized to that of GAPDH transcript. For each time point, the normalized amount of MCM4 transcript in mock
infection was set at 1.
doi:10.1371/journal.ppat.1000814.g006
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undetectable at G0 (0 h) but were expressed and recruited to
chromatin when cells re-entered the cell cycle (12–36 h). As
reported previously [17,18], HCMV infection slightly reduced
MCM accumulation at early times (12–24 h) but induced their
overall levels at late times (30–36 h), and MCM accumulation in
chromatin fractions from wild type HCMV-infected cells was
markedly reduced. The purity of our fractions was confirmed by
demonstrating that cellular protein lamin A was exclusively
present in chromatin fractions but not in soluble fractions, and
the vast majority of viral protein IE1 was present in soluble
fractions but not in chromatin fractions (Fig. 6C). pUL117 mutant
virus infection induced even higher MCM accumulation and failed
to efficiently block MCM recruitment to chromatin as compared
to wild type virus infection (most evident at 24–30 hpi). This
difference between wild type and mutant virus infection was
apparent for both MCM2 and MCM4, although the effect on
MCM4 was greater. The altered accumulation of MCM proteins
was likely to occur at a post-transcriptional level as MCM4
transcript accumulated at similar levels during HCMV infection
independent of pUL117 (Fig. 6D).
To better define the effect of pUL117 on MCM accumulation
and chromatin loading, we quantified total and chromatin
bound MCM protein levels at 24 and 30 hpi. It was clear that
both total and chromatin bound MCM levels markedly
increased in mutant virus infection relative to wild type virus
infection (Fig. 6B). At 24 hpi, the increase of chromatin-bound
MCM protein levels paralleled the increase of total MCM levels
in mutant virus infection. However, at 30 hpi, chromatin bound
MCM2 and MCM4 increased by 3.2- and 4.1- fold whereas
total MCM2 and MCM4 only increased by 1.7- and 1.8- fold,
respectively, in the absence of pUL117. These results suggest
that pUL117 inhibits replication licensing by reducing accumu-
lation of total MCMs (e.g. 24 hpi), and additionally, may by
targeting MCM chromatin loading (e.g. 30 hpi) during HCMV
infection.
An earlier study suggests that the premature accumulation of
geminin, a substrate of the anaphase-promoting complex
(APC), may block MCM chromatin loading in HCMV
infection [18]. Therefore, we examined the accumulation of
geminin and two other APC substrates, cdc6 and cyclin B1, in
mutant virus infection. As compared to mock infection,
elevated levels of all three APC substrates were evident as
early as 12 hpi and persisted throughout the course of infection
examined, consistent with previous reports (Fig. 7) [18,35,36].
However, this premature accumulation of APC substrates
during HCMV infection was independent of pUL117 expres-
sion. In fact, these APC substrates accumulated to even greater
levels in the absence of pUL117 at 36 and 48 hpi, perhaps due
to the increased transcription of these genes at late S and G2
phases in cells infected with the mutant virus. Thus, geminin is
unlikely to be targeted by pUL117 to modulate MCM
chromatin loading.
Taken together, our results suggest that pUL117 helps to block
cellular DNA synthesis during HCMV infection, at least in part,
by preventing the accumulation and loading of MCM onto
chromatin and subsequent replication licensing.
pUL117 expression alone is sufficient to inhibit MCM
accumulation and reduce cell proliferation
We next wanted to test if pUL117 was sufficient to inhibit
the accumulation and loading of MCM onto chromatin to
block host DNA synthesis. We created HFFs expressing a fully
functional GFP-tagged pUL117 (HF-GFP/UL117) [20] or
GFP control (HF-GFP) by retroviral transduction. To test the
hypothesis, transduced, G0-synchronized cells were stimulated
into active growth by re-seeding at sub-confluency with serum,
Figure 7. pUL117 was not required for premature accumulation of APC substrates in HCMV infection. Subconfluent HFFs were
synchronized at G0 by serum starvation, and then infected with recombinant HCMV in the presence of serum. At indicated times, total lysate from
equal number of cells were analyzed by immunoblotting for APC substrates cdc6, cyclin B1, and geminin. Also shown were pUL117-related proteins,
IE1 and actin control.
doi:10.1371/journal.ppat.1000814.g007
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modulation, and cell proliferation (Fig. 8). In GFP/UL117-
expressing cells, the rate of cellular DNA synthesis decreased
(54%) compared to GFP-expressing cells (100%) (Fig. 8C).
Moreover, the accumulation and chromatin loading of MCM
proteins were markedly reduced in these cells (Fig. 8A). Finally,
cell proliferation of GFP/UL117-expressing cells was substan-
tially slower relative to GFP-expressing control cells (Fig. 8D).
The effect of pGFP/UL117 was unlikely due to non-specific
toxic effect resulting from over-expression, since the level of
pGFP/UL117 was much lower than that of GFP control in
transduced cells (Figure S3). Quantitative immunoblot analysis
indicated that both the total and chromatin bound MCMs are
indeed markedly reduced in pGFP/UL117 expressing cells,
but the magnitude of reduction in the former paralleled that in
the latter (Fig. 8B). Thus, pUL117 alone exerts its effect
primarily by inhibiting MCM accumulation. During HCMV
infection, it may act with other viral factors to exert its
additional inhibitory effect to further reduce MCM chromatin
loading (Fig. 6B).
Knockdown of MCM proteins restores the ability of
pUL117-deficient virus to block host DNA synthesis
Modulation of MCM function has been suggested as one
mechanism for HCMV to block host DNA synthesis [17,18]. Our
study establishes a role for pUL117 in inhibiting MCM function and
host DNA synthesis during HCMV infection. We wanted to directly
test the role of MCMs in pUL117-mediated inhibition of cellular
DNA synthesis. We knocked down MCM2 and MCM4 by siRNA
transfection, infect transfected HFFs with HCMV, and examined
cellular DNA content in pUL44-positive cells at 48 hpi. MCM-
specific siRNAs reduced MCM2 and MCM4 proteins by ,80%
whereas control siRNA only had a negligible effect (Fig. 9A). As
expected, wild type virus blocked cellular DNA synthesis regardless
Figure 8. pUL117 was sufficient to inhibit proliferation and cellular DNA replication. HFFs were transduced with retro-viral vector either
expressing GFP (HF-GFP) or pUL117 (HF-GFP/UL117) as previously described [20]. (A) Cells were synchronized at G0 by serum starvation, stimulated
into the cell cycle by sub-confluent re-seeding with serum, and total cell lysate or chromatin fractions from equal number of cells were examined by
immunoblot analysis at indicated times. (B) MCM2 and MCM4 accumulation and their chromatin loading were quantified as described in the legend
to Fig. 6B. The ratio of MCM in GFP-transduced cells to that in GFP/UL117-transduced cells was calculated. Shown are the averages of the results from
three independent experiments. *, P,0.05; **, P,0.01; n.s. (not significant), P.0.05 by Student’s t test. (C) At 24 hpi, the rate of DNA synthesis was
measured by [
3H] thymidine incorporation. (D) In a parallel experiment, equal numbers of HF-GFP and HF-GFP/UL117 were re-seeded at sub-
confluency with serum and their proliferations were determined by scoring cell numbers during 24–120 h.
doi:10.1371/journal.ppat.1000814.g008
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a minimal effect on the cellular DNA content in pUL117-deficient
virus infected cells as 33% of mock- and 36% of control siRNA-
transfected cells reached S and G2/M phases (Fig. 9B). In great
contrast, transfection of MCM-specific siRNAs restored the ability of
pUL117-deficient virus to block cellular DNA synthesis. In mutant
virus infection, while 36% of control siRNA-transfected cells
reached S and G2/M phases, only 13% of MCM-specific siRNA-
transfected cells did so. This inhibitory effect was as potent as that
seen during wild type virus infection, in which 13% of cells also
reached S and G2/M phases. Thus, targeting MCM function is one
key mechanism for pUL117 to block host DNA synthesis.
Together, our results provide evidence that viral protein
pUL117 reduces accumulation of MCMs and helps to prevent
their loading onto chromatin. This activity is critical for HCMV to
block cellular DNA synthesis during infection.
Discussion
The DNA virus HCMV has an intrinsic ability to stimulate
DNA synthesis (Fig. 4), but host DNA synthesis is specifically
blocked during infection. Such modulation is pivotal for
herpesviruses to establish a successful lytic infection [2]. HCMV
proteins pUL69 and IE2 are two known viral proteins that exert
this regulatory activity. Inhibition of DNA replication licensing
was also proposed as one mechanism for HCMV to block host
DNA synthesis [17,18]. However, the viral factors targeting
replication licensing have not been documented. Here, we
identified pUL117 as a novel viral factor that inhibits replication
licensing by targeting the MCM helicase and blocks cellular DNA
synthesis upon HCMV infection. pUL117 expression is sufficient
to inhibit MCM protein accumulation and reduce cellular DNA
synthesis (Fig. 8). During infection, it may also act with other viral
factors to exert its additional inhibitory effect to further reduce
MCM chromatin loading (Fig. 6B). Importantly, MCM knock-
down by siRNA restores the ability of pUL117-deficient virus to
block cellular DNA synthesis (Fig. 9B). Thus, targeting MCM
complex is one key mechanism for pUL117 to block host DNA
synthesis in HCMV infection. This study also provides evidence to
support the previously proposed hypothesis that inhibition of
replication licensing is important for HCMV to block cellular
DNA synthesis.
It is also noteworthy to mention that other viral factors, such as
IE2 [15,16] and pUL69 [10,11], contribute to the ability of
HCMV to block host DNA synthesis. This is consistent with our
results that HCMV was still able to largely prevent host DNA
replication at early times and impose additional, post-G1 blocks at
late times in the absence of pUL117 (Figs. 2C and 3A). This may
also explain why targeting MCM is so efficient to block cellular
DNA synthesis in HCMV infected cells but not in uninfected cells.
MCMs are normally loaded onto chromatin in a great excess over
DNA synthesis initiation events [37,38]. Knockdown of MCMs by
RNAi may not have an immediate effect as minimally licensed
chromatin continues to support DNA replication [39,40]. This is
consistent with our result that knockdown of MCM2 and MCM4
only has a subtle effect on the DNA content of uninfected cells
(Fig. 9B). However, HCMV encodes several other inhibitory
proteins (i.e. IE2 and pUL69) and introduces many changes
during infection, which may render cellular DNA synthesis hyper-
sensitive to reduced MCM levels. Our results substantiate the
general strategy of HCMV to use multiple viral proteins to subvert
related cellular processes for its own replication.
As chromatin loading of MCMs precedes the initiation of DNA
synthesis at S-phase, it is conceivable that targeting MCM
complex by pUL117 enables HCMV to block cellular DNA
synthesis while maintaining an S-phase like environment. During
infection, several viral proteins, such as pp71, IE1, IE2, and
pUL97 inactivate pRb, create a cellular environment conducive to
DNA synthesis, and stimulate transcription of E2F-responsive
genes, including MCM proteins (reviewed in [5])[1]. On the other
hand, accumulation of MCM proteins is delayed and chromatin
loading of MCM proteins is reduced in HCMV-infected cells
[17,18]. In addition, HCMV also appears to modulate post-
licensing events by blocking hyper-phosphorylation of MCM2 at
24–48 hpi and inducing hyper-phosphorylation of MCM4 at 48–
72 hpi in G0-synchronized HFFs [18]. We have also observed
MCM4 hyper-phosphorylation at late times during mutant and
wild type HCMV infection (data not shown). However, the roles of
such modulation need to be further tested. pUL117 appears to
target MCM complex primarily by reducing its total levels when
Figure 9. Knockdown of MCM2 and MCM4 restores the ability of pUL117-deficient virus to block host DNA synthesis. HFFs were
transfected with a negative control siRNA or siRNAs targeting MCM2 and MCM4. (A) Immunoblot analysis of MCM 2 and MCM4 at 48 hours after
siRNA transfection. (B) Transfected cells were starved and infected in the presence of GCV (30mg/ml) as described in Materials and Methods, double-
stained with PI and a-pUL44 at 48 hpi, and pUL44+ cells were determined for their DNA content. Percentages of cells in S-phase or G2/M-phases were
shown as solid or open bars, respectively. Shown is a representative from three reproducible, independent experiments.
doi:10.1371/journal.ppat.1000814.g009
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24 hpi). However, the reduction in MCM loading is significantly
greater than the reduction in their total accumulation at 30 hpi.
Therefore, pUL117 may have other means to target MCM
loading in addition to reducing their total accumulation. The exact
mechanism for this remains to be elucidated as co-immunopre-
cipitation studies failed to reveal evidence for a direct interaction
of pUL117 with pre-RC components (data not shown). Further-
more, we cannot rule out the possibility that pUL117 may also
target other cellular factors to excise its full inhibitory activity.
How does this inhibitory activity of pUL117 impact the
replication cycle of HCMV? We previously showed that
pUL117-deficient virus was defective in growth and maturation
of viral nuclear replication compartments [20]. It is intriguing to
speculate that the pUL117-mediated inhibition of host DNA
synthesis may prevent downstream detrimental responses to
unscheduled cellular DNA synthesis to allow the development of
replication compartments, a critical event of the viral infection
cycle. Work is in progress to dissect the molecular basis of pUL117
activity and the engagement of MCM in replication compartment
maturation during HCMV infection.
DNA viruses employ sophisticated strategies to subvert host
DNA replication machinery and cell cycle control pathways to
promote their own replication. By driving host cells into an S-
phase like environment, viruses promote the accumulation of
DNA synthesis components and other cellular factors required for
their own production. However, many viruses inhibit host DNA
synthesis at critical stages of their replication cycle. Examples
include adeno-associated virus (AAV) [41], human papillomavirus
(HPV) [42,43], and herpesviruses [2]. How do these viruses block
cellular DNA synthesis in an S-phase like environment? Viruses
can accomplish this by modulating an array of DNA replication
factors, and MCM proteins emerge as key targets in this strategy.
AAV modulates multiple factors required for cellular DNA
synthesis. It reduces cyclin-dependent kinase activity and sustains
hypophosphorylation of pRb [41,44,45]. It also encodes viral
DNA replication protein Rep that binds to MCM proteins [46]
and inhibits cellular DNA synthesis [44,45]. It is conceivable that
Rep hijacks MCM proteins for viral DNA replication, and
simultaneously prevents MCM loading onto host chromatin.
Over-expression of the HPV E4 protein prevents MCM protein
loading onto host chromatin and inhibits cellular DNA synthesis
[42]. Among herpesviruses, Epstein-Barr virus (EBV) induces
phosphorylation of MCM4 to inhibit the DNA helicase activity of
MCM complex during lytic infections [47]. When over-expressed,
an EBV-encoded protein kinase phosphorylates MCM4 and
causes cell cycle arrest. However, to our knowledge, the roles of
these viral proteins in MCM modulation in the context of virus
infection have not been reported. We have identified pUL117 as a
viral factor that manipulates MCM during HCMV infection and
our results exemplify deregulation of MCM function as a
conserved strategy for diverse viruses to prevent host DNA
synthesis. Understanding how pUL117 inhibits MCM at a
mechanistic level will not only help to elucidate how diversified
virus species have evolved to converge on common cellular targets,




pYD-C160 and pYD-C305 are pRetro-EBNA based retroviral
vectors [48] that express GFP and the GFP-UL117 fusion protein,
respectively. Primary antibodies used in this study include: a-
pUL117 [20], a-IE1 [49] (a gift from Thomas Shenk at Princeton
University), a-pUL44 (Virusys), a-IE1/IE2 (a gift from Jay Nelson
at Oregon Health and Science University), a-actin, a-GFP, a-
MCM2 (all three from Abcam), a-p16
Ink4a (Neomarkers), a-
MCM4 (BD Pharmingen), a-lamin A (Biolegend), a-cdc6
(Upstate), a-cyclin B1 (Thermo Scientific), a-cyclin A, a-geminin,
a-p53, a-p21 (all four from Santa Cruz Biotechnology). Shld1 was
a gift from Thomas Wandless at Stanford University. Ganciclovir
(GCV), phosphonoacetic acid (PAA), and propidium iodide (PI)
were purchased from Sigma. [Methyl-
14C] and [Methyl-
3H]
thymidines were purchased from Perkin Elmer. siLentFect lipid
reagent was purchased from Bio-Rad. siGENOME Non-Target-
ing siRNA #2 and siGENOME SMARTpool siRNA targeting
human MCM2 and MCM4 were purchased from Thermo
SCIENTIFIC. The MCM2 targeted sequences are: 59-GAA
GAU CUU UGC CAG CAU U-39,5 9-GGA UAA GGC UCG
UCA GAU C-39,5 9-GCC GUG GGC UCC UGU AUG A-39,
and 59-GGA UGU GAG UCA UGC GGA U-39. The MCM4
targeted sequences are: 59-GGA CAU AUC UAU UCU UAC U-
39,5 9-GAU GUU AGU UCA CCA CUG A-39,5 9-CCA GCU
GCC UCA UAC UUU A-39, and 59-GAA AGU ACA AGA
UCG GUA U-39.
Cells and viruses
Primary human foreskin fibroblasts (HFFs) were propagated in
Dulbecco’s modified Eagle medium (DMEM) supplemented with
10% fetal calf serum. To generate HFFs expressing the GFP-
UL117 fusion protein (HF-GFP/UL117) or GFP (HF-GFP),
retrovirus stocks were made from transfection of retroviral vector
pYD-C305 or pYD-C160, respectively, and then used to
transduce HFFs as previously described [50]. Various recombi-
nant HCMV AD169 viruses were reconstituted from transfection
of corresponding BAC-HCMV clones as described [20]. Viral
stocks were prepared by ultra-centrifuging of infected culture
supernatant through 20% D-sorbitol cushion and re-suspending
pelleted virus in serum-free medium. pUL117-deficient frame-shift
mutant virus ADdlpUL117 was created and previously described
as ADinUL117
C19-1nt [20]. The recombinant HCMV virus
ADpFKBP-UL117 was reconstituted from the BAC-HCMV clone
in which UL117 was tagged with a FKBP destabilization domain
(ddFKBP) sequence at its 59-end by linear recombination as
described previously [20]. The DNA fragment containing the
ddFKBP coding sequence used for recombination was amplified
by PCR from plasmid pENTR221-FKBP [27] using a primer pair
(59-CGT GTG GAG CCG TAG ACG ATC TGG ACG TGG
TCC TGG GAG AAC ATG ACC ATT TCT TCC GGT TTT
AGA AGC T-39 and 59-CCC TCA GCC TCT GTG TTC CCA
ACA CGT CCC CCC GCT GAG CGT TGG CGG CGA TGG
GAG TGC AGG TGG AAA C-39).
HCMV infection
To prepare actively growing HFFs, cells synchronized at G0/
G1 by contact inhibition were stimulated into the cell cycle by re-
seeding at sub-confluency with serum-containing medium for
36 hours, a time where ,90% of cells were at G1 phase (data not
shown). To prepare G0-synchronized HFFs, sub-confluent or
confluent cells were starved in serum-free medium for 72 hours.
Cells were then infected with recombinant HCMV at a tissue
culture infectious dose 50 unit (TCID50) of 5, with or without
serum (10%) and specific viral DNA replication inhibitors (GCV
[30 mg/ml unless indicated otherwise] or phosphonoacetic acid
(PAA) [100 mg/ml]) as needed. If GCV or PAA was used, new
GCV- or PAA- containing medium was replenished every
48 hours to maintain its efficacy. Where necessary, nocodazole
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cell cycle progression.
siRNA knockdown
To knockdown MCM2 and MCM4 in HFFs, subconfluent
HFFs were mock-transfected, or transfected with control siRNA or
siGENOME SMARTpool siRNA targeting human MCM2 and
MCM4 by siLentFect lipid reagent according to manufacturer’s
instruction (Bio-Rad). Transfected cells were starved in serum-free
medium for 3 days and then infected as described above in serum
(10%)-containing medium in the presence of GCV (30 mg/ml).
Nocodazole (100 ng/ml) was added at 8 hpi to prevent the second
round of the cell cycle progression.
Analysis of cellular and viral DNA
To determine the cellular DNA content, HFFs were removed
from culture dish by trypsinization, collected by low-speed
centrifugation, fixed, and permeabilized in ice-cold 70% ethanol
overnight. Cells were then stained with propidium iodide (PI) only,
or double-stained with PI and a-IE1/IE2 or a-pUL44 to identify
lytically infected cells. Infected cells that were unsorted, sorted by
virus-driven GFP expression, or gated by antibody staining to
IE1/IE2 or pUL44 were determined for their DNA content by
cell-cycle analysis with flow-cytometry. Percentages of cells in each
cell cycle compartment were calculated using the Cell Quest
software.
To measure the rate of DNA synthesis, HFFs were first labeled
with [
14C] thymidine overnight. For infection, cells were then
starved in serum-free medium for 72 hours before infected with
HCMV in the presence of GCV (30 mg/ml). For over-expression,
cells were then transduced with expressing retrovirus, starved in
serum-free medium for 72 hours, and subsequently stimulated into
the cell cycle by sub-confluent re-seeding in serum (10%)-
containing medium. At proper times, infected or transduced cells
were labeled with [
3H] thymidine for 2 hours, DNA was recovered
by trichloroacetic precipitation, washed with phosphate-buffered
saline, and [
3H] and [
14C] incorporation were measured by a
liquid scintillation counter. The amount of [
3H] incorporated was
normalized to that of [
14C] incorporated. Experiments were
performed in biological triplicate and the P value associated with
Student’s paired t-test with a two-tailed distribution was used for
statistical analysis.
To prepare intra-cellular DNA for quantification by realtime-
quantitative PCR, HCMV-infected HFFs were collected at various
times post infection, re-suspended in 26 lysis buffer (200 mM
NaCl, 20 mM Tris [pH 8.0], 50 mM EDTA, 0.2 mg/ml
proteinase K, 1% sodium dodecyl sulfate [SDS]) that was spiked
with 28 ng/ml of a human ATF4 cDNA-containing plasmid [50],
and incubated at 55uC overnight. DNA was extracted with
phenol-chloroform, precipitated with ethanol, and re-suspended in
nuclease-free water (Ambion). Viral DNA was quantified by
realtime-quantitative PCR as previously described [20] using a
TaqMan probe (Applied Biosystems) and primers specific for the
HCMV UL54 gene [12]. Cellular and spiked DNA was quantified
with SYBR Advantage qPCR Premix (Clonetech) and primer
pairs specific for the human b-actin gene [20] and the human
ATF4 cDNA [50], respectively. pUL117-deficient virus and wild
type virus differentially modulated cellular DNA synthesis, and
therefore the spiked ATF4 cDNA that was in ,1,000-fold excess
to genomic DNA was used to normalize samples. The accumu-
lation of viral DNA was normalized by dividing UL54 gene
equivalents by ATF4 cDNA equivalents. The accumulation of
pUL117-deficient viral DNA in the presence of GCV was set as 1.
Protein and transcript analysis
Protein accumulation was analyzed by immunoblotting [20] or
flow cytometry. For immunoblotting, cells were collected, washed,
and lysed in the sodium dodecyl sulfate (SDS)-containing sample
buffer. Proteins from equal cell numbers were resolved by
electrophoresis on a SDS-containing polyacrylamide gel, trans-
ferred to a PVDF membrane, hybridized with primary antibodies,
reacted with HRP-conjugated secondary antibodies, and visual-
ized by SuperSignal West Pico Chemiluminescent Substrate
(Thermo Scientific). For quantitative immunoblotting, total cell
lysate and chromatin fractions from equal number of cells were
diluted in serial two-fold dilutions and then analyzed by
immunoblotting for MCM2 and MCM4. The intensity of protein
band signals was determined by imageJ software (NIH). Only
dilutions that produce protein bands with the intensity within the
linear range were used for calculation. To further reduce
systematic variations, protein bands from different samples with
the most similar intensity were used. The ratio of the MCM in
sample A to that in sample B is calculated based on the intensities
and dilution factors of the samples: MCM of A / MCM of
B=(intensity of A/intensity of B)*(dilution factor of A/dilution
factor of B). For flow cytometry, infected HFFs were collected and
fixed with 1% paraformaldehyde, labeled with a-pUL44 and
Alexa fluor 647 labeled anti-mouse antibody (Invitrogen), and
analyzed for expression of pUL44 and HCMV-driven GFP by
flow cytometry.
Transcript accumulation was analyzed by reverse transcrip-
tion-coupled realtime-quantitative PCR as previously described
[50]. Total RNA was extracted using the Trizol reagent
(Invitrogen) and treated with the TURBO DNA-free reagent
(Ambion). cDNA was reverse transcribed with random hexamer
primers using the High Capacity cDNA Reverse Transcription
Kit (Applied Biosystems), and quantified by real-time qPCR using
the SYBR Advantage qPCR Premix (Clontech) and primer pairs
specific for human genes MCM4 (59-TGT GGC AGC ATG
CAA AGA A-39 and 59-GGG TCA ATA AAA CGC TGA AGA
AA-39) [51] and GAPDH (59-CTG TTG CTG TAG CCA AAT
TCG T-39 and 59-ACC CAC TCC TCC ACC TTT GAC-39).
The amount of MCM4 was normalized using GAPDH as the
internal control.
Subnuclear fractionation
Chromatin fractions were prepared to analyze the loading of
MCM as previously described [52]. Cells were collected, washed
twice with cold phosphate-buffered saline, and lysed in modified
CSK buffer (10 mM PIPES, pH 6.8, 100 mM NaCl, 300 mM
sucrose, 3 mM MgCl2, 0.5% Triton X-100) containing protease
inhibitors (Protease Inhibitor Cocktail, Roche), 1 mM PMSF,
phosphatase inhibitors (Phosphatase Inhibitor Cocktail 1 and 2,
Sigma), and 1 mM ATP. Cells were incubated on ice for 10 min
and then centrifuged at 8506g for 5 min at 4uC. The pellet was
washed, re-suspended in lysis buffer by sonication, dissolved in
SDS-containing sample buffer, and analyzed by SDS-PAGE and
immunoblotting.
Supporting Information
Figure S1 pUL117 was required to block host DNA synthesis of
G0-synchronized HFFs during HCMV infection. Subconfluent
HFFs were synchronized at G0 by serum starvation and then
infected with recombinant HCMV in the presence of serum.
Nocodazole was added at 8 hpi. Cells were infected in the
presence phosphonoacetic acid (PAA) (100 mg/ml), double-
stained with PI and a-pUL44 at 24 and 48 hpi, and analyzed
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Shown is a representative of three reproducible, independent
experiments. (A) Signal profiles of pUL44 (x-axis) and PI (y-axis)
of mock- or virus- infected cells at 48 hpi. Cells within gate R3 or
R4 represents pUL44-negative or pUL44-positive cells, respec-
tively. (B) Mock-infected cells in R3 and virus-infected cells in R4
were analyzed for their DNA content. Percentages of cells in S-
phase or G2/M-phases were shown as solid or open bars,
respectively.
Found at: doi:10.1371/journal.ppat.1000814.s001 (7.22 MB TIF)
Figure S2 pUL117 was not required for HCMV to modulate
accumulation of p53, p21 or p16 during infection. Subconfluent
HFFs were synchronized at G0 by serum starvation, and then
infected with recombinant HCMV in the presence of serum. At
indicated times, total lysate from equal number of cells were
analyzed by immunoblotting for p53, p21 and p16. Also shown
were IE1 and actin controls.
Found at: doi:10.1371/journal.ppat.1000814.s002 (1.79 MB
TIF)
Figure S3 The GFP/UL117 fusion protein was not expressed at
a higher level than GFP control in stably transduced HFFs.
Lysates from equal number of HFFs transduced with retrovirus
expressing GFP or pGFP/UL117 were analyzed by immunoblot-
ting with a-GFP antibody.
Found at: doi:10.1371/journal.ppat.1000814.s003 (1.42 MB TIF)
Figure S4 SSC and FSC gates of HFFs infected with wild type
or mutant virus. Shown are the gates for HFFs infected with ADwt
or ADdlUL117 and labeled with a-pUL44 antibody as described
in Fig. 2B.
Found at: doi:10.1371/journal.ppat.1000814.s004 (1.48 MB TIF)
Figure S5 Standard and dissociation curves for MCM4 and
GAPDH real time qRT-PCR. Shown are the part of the raw data
used to generate the results in Fig. 6C.
Found at: doi:10.1371/journal.ppat.1000814.s005 (10.05 MB
TIF)
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